TLR3 and inflammatory bowel disease: Therefore, we aimed to assess whether inhibiting TLR3, 7, or 9 reduces the numbers of colonic IFN-γ+/IL-17+ double-positive foci as well as the intensity of intestinal inflammation in the IBD mouse model administered the EBV DNA.